TimesSquare Capital Management LLC Takes $31.50 Million Position in Addus HomeCare Corporation $ADUS

TimesSquare Capital Management LLC bought a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the 2nd quarter, Holdings Channel.com reports. The firm bought 313,549 shares of the company’s stock, valued at approximately $31,502,000.

A number of other hedge funds have also recently bought and sold shares of ADUS. Global Retirement Partners LLC raised its position in Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares in the last quarter. Larson Financial Group LLC boosted its position in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC acquired a new position in shares of Addus HomeCare in the 4th quarter worth approximately $29,000. Arax Advisory Partners grew its stake in shares of Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares during the last quarter. Finally, Private Trust Co. NA raised its holdings in shares of Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $114.90 on Tuesday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The company has a market cap of $2.15 billion, a PE ratio of 20.16, a PEG ratio of 1.56 and a beta of 0.87. The stock’s 50-day moving average price is $107.32 and its two-hundred day moving average price is $102.01.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.70 by $0.03. The company had revenue of $377.41 million during the quarter, compared to analysts’ expectations of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period last year, the company posted $1.49 earnings per share. On average, analysts predict that Addus HomeCare Corporation will post 6.29 EPS for the current year.

Insider Activity at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company’s stock.

Wall Street Analyst Weigh In

ADUS has been the subject of several recent research reports. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Monday, May 18th. Barclays increased their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th. Finally, Royal Bank Of Canada raised their price objective on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $130.88.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.